NEWS

NEWS

新闻资讯

Company news

Industry news

2025-07-09

Nanolattix Chairperson Dr. Zhican Qu Attends BIO 2025, Showcasing China's Biopharma Innovation

Nanolattix Chairperson Dr. Zhican Qu Attends BIO 2025, Showcasing China's Biopharma Innovation

Learn more

2025-07-09

Clinical Trial Recruitment for T320, a Novel TF-Targeting Anti-Cancer Drug

Clinical Trial Recruitment for T320, a Novel TF-Targeting Anti-Cancer Drug

Learn more

2025-07-09

Nanolattix’s T320-ADC Multi-Center Clinical Trials Initiated, Accelerating Development of Advanced Solid Tumor Therapies

Nanolattix’s T320-ADC Multi-Center Clinical Trials Initiated, Accelerating Development of Advanced Solid Tumor Therapies

Learn more

Dr. Qu Zhican Takes Stage at 2025 China Pharmaceutical Innovation Summit and Delivers Keynote Speeches on RDC and ADC

Dr. Qu Zhican Takes Stage at 2025 China Pharmaceutical Innovation Summit and Delivers Keynote Speeches on RDC and ADC

01

2025/12

Nanolattix Attends 10th Guangzhou (Greater Bay Area) Biopharma Innovation Summit, Shares Advancements in ADC and RDC Therapeutics

Nanolattix Attends 10th Guangzhou (Greater Bay Area) Biopharma Innovation Summit, Shares Advancements in ADC and RDC Therapeutics

11

2025/11

Nanolattix Presents at BIO-Europe 2025; T320-ADC Garners Overseas Market Attention

Nanolattix Presents at BIO-Europe 2025; T320-ADC Garners Overseas Market Attention

11

2025/11

Dr. Qu Zhican Attends World ADC Conference, Unveils Nanolattix's Innovative "ADC + RDC Theranostic Integration" Strategy

Dr. Qu Zhican Attends World ADC Conference, Unveils Nanolattix's Innovative "ADC + RDC Theranostic Integration" Strategy

11

2025/11

Dr. Qu Zhican, Chairman of Nanolattix, Attends Dingxiangyuan BD Collaboration Salon and Delivers Keynote Speech

Dr. Qu Zhican, Chairman of Nanolattix, Attends Dingxiangyuan BD Collaboration Salon and Delivers Keynote Speech

04

2025/11

Dr. Qu Zhican, Chairman of Nanolattix, Attends the 10th China BioMed Innovation and Investment Conference and Delivers Keynote Speech

Dr. Qu Zhican, Chairman of Nanolattix, Attends the 10th China BioMed Innovation and Investment Conference and Delivers Keynote Speech

04

2025/11